This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Rovensky, J Articles by Vigas, M Search for Related Content PubMed PubMed Citation Articles by Rovensky, J Articles by Vigas, M Social Bookmarking                         What's this?

The hypothalamic-pituitary response in SLE. Regulation of prolactin, growth hormone and cortisol release

J Rovensk

S Blaíková

L Rauovaá

Research Institute for Rheumatic Diseases, Piet'any

D Jeová

J Koka

Institute for Experimental Endocrinology, Slovak Academy of Sciences, Bratislava, Slovak Republic

J Luká

Research Institute for Rheumatic Diseases, Piet'any

M Viga

Institute for Experimental Endocrinology, Slovak Academy of Sciences, Bratislava, Slovak Republic

It has been suggested that neuroendocrine regulation plays an important role in the pathogenesis and activation of autoimmune diseases. The aim of this investigation was to clarify the hypothalamic-pituitary response to a well-defined stimulus under standardised conditions in patients with SLE. Plasma concentrations of prolactin (PRL), growth hormone (GH) and cortisol were determined in venous blood drawn through an indwelling cannula during insulin-induced hypoglycaemia (0.1 U/kg b.w., i.v.) in ten patients and in 12 age-, gender-and weight-matched healthy subjects. Basal PRL concentrations were higher in patients vs healthy controls (12 vs 6ng/ml, P < 0.01), though still within the physiological range. Insulin-induced plasma PRL and GH were significantly increased both in patients and healthy subjects; however, the increments or areas under the curves were not different in the two groups. Plasma cortisol response showed moderate attenuation in patients. Sensitivity of pituitary lactotrothrops to thyrotropin-releasing hormone (TRH) administration (200 mg, i.v.) was the same in patients and control subjects. In SLE patients with low activity of the disease the sensitivity of pituitary PRL release to TRH administration remained unchanged. The hypothalamic response to stress stimulus (hypoglycaemia) was comparable in patients and healthy subjects.

Key Words: systemic lupus erythematosus (SLE) • prolactin (PRL) • TRH test • hypoglycaemia • stress

Lupus, Vol. 7, No. 6, 409-413 (1998)
DOI: 10.1191/096120398678920325


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				S E Walker and L.-y. Yu-Lee Overview: prolactin and autoimmunity Lupus, October 1, 2001; 10(10): 659 - 659. [PDF]

				Y-S Bae, S-C Bae, S-W Lee, D-H Yoo, T Y Kim, and S Y Kim Lupus flare associated with growth hormone Lupus, June 1, 2001; 10(6): 448 - 450. [Abstract] [PDF]

				S E Walker, D Miller, D L Hill, and G R Komatireddy Prolactin, a pituitary hormone that modifies immune responses: Proceedings of the Mini-symposium on Prolactin and SLE, held at the 5th International Conference on Systemic Lupus Erythematosus, Cancun, Mexico Lupus, July 1, 1998; 7(6): 371 - 375. [PDF]